Live Breaking News & Updates on Relay Therapeutics Company Profile Get Rating

Stay updated with breaking news from Relay therapeutics company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vaxart (NASDAQ:VXRT) versus Relay Therapeutics (NASDAQ:RLAY) Critical Contrast

Vaxart (NASDAQ:VXRT – Get Rating) and Relay Therapeutics (NASDAQ:RLAY – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings. Volatility and Risk Vaxart has a beta of 0.41, indicating that […] ....

United States , United Kingdom , South San Francisco , Allostery Inc , Relay Therapeutics Inc , De Shaw Research , Vaxart Company Profile Get Rating , Relay Therapeutics Company Profile Get Rating , Vaxart Inc , Genentech Inc , Get Rating , Relay Therapeutics , Given Vaxart , Relay Therapeutic , Company Profile , Therapeutics Company Profile , Shaw Research , Nasdaq Vxrt , Stock Comparison , Stock Analysis ,

CEL-SCI (NYSE:CVM) versus Relay Therapeutics (NASDAQ:RLAY) Head to Head Comparison

Relay Therapeutics (NASDAQ:RLAY – Get Rating) and CEL-SCI (NYSE:CVM – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership. Risk and Volatility Relay Therapeutics has a beta of 1.66, meaning […] ....

United States , United Kingdom , Company Profile Get Rating , Allostery Inc , Relay Therapeutics Inc , De Shaw Research , University Of Georgia Center , Genentech Inc , Relay Therapeutics Company Profile Get Rating , Relay Therapeutics , Get Rating , Given Relay Therapeutic , Therapeutics Company Profile , Shaw Research , Ligand Epitope Antigen Presentation System , Nasdaq Rlay , Stock Comparison , Stock Analysis ,

Relay Therapeutics, Inc. (NASDAQ:RLAY) Expected to Announce Earnings of -$0.63 Per Share

Analysts expect that Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) will post ($0.63) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have provided estimates for Relay Therapeutics’ earnings. The lowest EPS estimate is ($0.64) and the highest is ($0.63). Relay Therapeutics posted earnings of ($0.47) per share in the same quarter […] ....

Sanjiv Patel , Thomas Catinazzo , Berenberg Bank , Zacks Investment Research , Blackrock Inc , Bellevue Group , Jpmorgan Chase Co , Relay Therapeutics Inc , Casdin Capital , Relay Therapeutics Company Profile Get Rating , Relay Therapeutics , Get Rating , Relay Therapeutic , Investment Research , State Street Corp , Street Corp , Therapeutics Company Profile , Nasdaq Rlay ,

Relay Therapeutics, Inc. (NASDAQ:RLAY) Expected to Post Earnings of -$0.63 Per Share

Wall Street brokerages expect Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Rating) to report earnings per share (EPS) of ($0.68) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Relay Therapeutics’ earnings. The lowest EPS estimate is ($0.64) and the highest is ($0.63). Relay Therapeutics posted earnings of ($0.47) […] ....

Donalda Bergstrom , Russell Investments Group Ltd , Berenberg Bank , Zacks Investment Research , Nisa Investment Advisors , Relay Therapeutics Inc , Relay Therapeutics Company Profile Get Rating , Royal Bank , Wall Street , Relay Therapeutics , Get Rating , Zacks Investment , Relay Therapeutic , Investments Group , Investment Advisors , Dark Forest Capital Management , Forest Capital Management , Therapeutics Company Profile , Nasdaq Rlay ,

Relay Therapeutics (RLAY) versus Its Rivals Financial Contrast

Relay Therapeutics (NASDAQ:RLAY – Get Rating) is one of 252 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors? We will compare Relay Therapeutics to similar businesses based on the strength of its profitability, analyst recommendations, valuation, risk, institutional ownership, dividends and earnings. Insider and […] ....

United Kingdom , United States , Allostery Inc , Relay Therapeutics Inc , De Shaw Research , Relay Therapeutics Company Profile Get Rating , Genentech Inc , Relay Therapeutics , Get Rating , Given Relay Therapeutic , Relay Therapeutic , Therapeutics Company Profile , Shaw Research , Nasdaq Rlay , Stock Comparison , Stock Analysis ,